Navigation Links
Edwards Lifesciences Announces Organizational Changes
Date:2/18/2008

IRVINE, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, today announced the company's strengthened alignment into a business unit organizational structure, along with the planned departure in the middle of 2008 of corporate officers Anita B. Bessler, Stuart L. Foster, and Alex Martin.

"To support our growth strategy, we have recently made product portfolio changes and increased investment in our market-leading businesses. As a result, we can now further our evolution into customer-focused business units and simplify our organization," said Michael A. Mussallem, Edwards' chairman and CEO. "We express our sincere thanks and gratitude to Anita, Stu and Alex for their significant contributions to Edwards over the years. Consistent with our Credo, they have served as trusted partners with patients, employees, customers and shareholders to provide innovative solutions for people fighting cardiovascular disease."

Bessler, who joined the company in 1988 and led the growth of Edwards' heart valve business into its current position as the global market leader, will continue in an ongoing advisory role with Edwards.

Foster, who joined the company in 1994 and served as the company's technology leader and oversaw the development and growth of the critical care and vascular businesses, will also continue in an ongoing advisory role with Edwards.

Martin, who joined Edwards in 2004, plans to pursue other opportunities upon his departure. He oversaw the development and expansion of the company's North American sales and marketing organization, Edwards' largest operating region.

As a result of the operational integration announced today, corporate officers Donald E. Bobo, Jr., Paul C. Redmond, Carlyn D. Solomon, and Larry L. Wood will assume management of additional U.S. sales, marketing and operational functions within their business units, and will report directly to Mussallem. In addition, corporate officer Corinne H. Lyle will undertake additional global responsibilities.

About Edwards Lifesciences

Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.


'/>"/>
SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Edwards Lifesciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
2. Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008
3. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
4. Edwards Lifesciences Completes Acquisition of CardioVations Product Line
5. Edwards Lifesciences Forecasts Strong Growth in 2008
6. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
7. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
10. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
11. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)...  The Maryland House of Delegates and House Speaker ... of Maryland School of Medicine Dean E. Albert ... Medical System President and CEO Robert Chrencik , ... honor given to the public by the leader of ... and Mr. Chrencik for their contributions to our ...
(Date:2/10/2016)... (PRWEB) , ... February 10, ... ... REGN) today announced that it has joined the Human Vaccines Project, a ... infectious diseases and cancer. , The Human Vaccines Project brings together ...
(Date:2/10/2016)... 10, 2016  Matchbook, Inc., a company specializing ... biotech companies, announced today the appointment of ... Jim brings nearly 25 years of experience in ... spent nearly two decades in executive level roles ... at Genzyme and, most recently headed global logistics ...
(Date:2/10/2016)... ... 10, 2016 , ... LATHAM, NEW YORK... Marktech Optoelectronics will feature ... in San Francisco’s Moscone Center from February 16-18, 2016, and at the healthcare-focused ... latest InGaAs PIN diode standard packages feature a TO-46 metal can with active areas ...
Breaking Biology Technology:
(Date:2/11/2016)... , Feb. 11, 2016  Vigilant Solutions announces today that ... are being used by Lee,s Summit ... recent location and arrest of a homicide suspect. ... covers around 65 square miles and is home to ... Department has a single mobile license plate reader system and ...
(Date:2/8/2016)... 8, 2016 Worldcore ... presents innovation for clients, comfort and unbeatable security, ... --> Worldcore is the first ... clients, comfort and unbeatable security, with a Voice ... Worldcore is the first EU-regulated global ...
(Date:2/3/2016)... 2016 --> ... "Automated Fingerprint Identification System Market by Component (Hardware and ... & Finance, Government, Healthcare, and Transportation) and Geography - ... is expected to be worth USD 8.49 Billion by ... and 2020. The transformation and technology evolution from the ...
Breaking Biology News(10 mins):